Skip to content
MedsAcross

Medicine

Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) 100 IU/100 IU per mL powder for injection

Available on requestPrescription onlyUS FDA Cold chain

Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) 100 IU/100 IU per mL powder for injection is a prescription medicine containing Antihemophilic factor human and Von willebrand factor human for intravenous use, marketed by Octapharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store WILATE for up to 36 months at +2°C to +8°C (36°F to 46°F) in the…

Key facts

Active ingredient (INN)
Antihemophilic factor human and Von willebrand factor human
Brand
Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Strength
100 IU/100 IU per mL
Dosage form
Powder for injection
Route
Intravenous
Packs
5 mL, 10 mL
Marketing authorisation holder
Octapharma
Manufacturer
Octapharma
Origin register
US FDA, United States
Storage
Store WILATE for up to 36 months at +2°C to +8°C (36°F to 46°F) in the original containers to protect from light from the date of manufacture. Within this period, WILATE may be stored for a period of up to 6 months at room temperature (maximum of +25°C or 77°F). The starting date of room temperature storage should be clearly recorded on the product carton.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3002.12Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
4 December 2009
Identifiers
RxCUI 1661332, 1661335DailyMed set ID a8ef06b8-b041-054e-e58d-fd8a994a8071NDC 68982-182Application BLA125251

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
5 mL in 1 vial68982-182-01Octapharma4 December 2009
10 mL in 1 vial68982-182-02Octapharma4 December 2009

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Antihemophilic factor human and Von willebrand factor human is a fixed-dose combination of a human antihemophilic factor and a human blood coagulation factor. MedsAcross supplies Antihemophilic factor human and Von willebrand factor human for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Antihemophilic factor human and Von willebrand factor human

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) 100 IU/100 IU per mL powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.